v3.23.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash Flows from Operating Activities    
Net Loss $ (3,204,819) $ (6,916,507)
Adjustments to reconcile change in net loss to net cash used in operating activities:    
Depreciation and amortization 525,631 682,068
Stock-based compensation expense 103,809 1,226,357
Value of common stock issued in exchange for consulting services 71,940 22,698
Changes in operating assets and liabilities which used cash:    
Accounts Receivable (29,205) 40,325
Prepaid expenses and other current assets 386,086 (265,295)
Accounts payable (27,794) 297,621
Accrued compensation (92,856) (19,612)
Deferred revenue (236,692) (114,010)
Accrued and other liabilities (79,595) (42,465)
Net cash and cash equivalents (used) in operating activities (2,583,495) (5,088,820)
Cash Flows from Investing Activities    
Purchase of property and equipment (5,554) (14,267)
Investment in capitalized software (288,209) (574,123)
Net cash and cash equivalents (used) in investing activities (293,763) (588,390)
Cash flows from Financing Activities - Issuance of common stock - net of issuance costs 1,850,501 3,869,550
Net (decrease) in cash and cash equivalents (1,026,757) (1,807,660)
Cash and cash equivalents, beginning of period 7,155,367 10,713,091
Cash and cash equivalents, end of period 6,128,610 8,905,431
Significant Noncash Transactions:    
Acquisition of capitalized software included in accounts payable and accrued liabilities 70,924
Issuance of common stock in exchange for consulting services $ 22,698

Source